INS and Insulin resistance: In contrast with the reported beneficial effects of CPAP on glucose metabolism and insulin resistance in OSA patients, some studies demonstrated that CPAP treatment for 3 or 6 months did not improve fasting glucose or insulin plasma levels (Ip et al., 2000).